AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (February 21, 2008). doi:10.1152/ajpgi.00057.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/5/G1101    most recent
00057.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kunos, G.
Right arrow Articles by Osei-Hyiaman, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunos, G.
Right arrow Articles by Osei-Hyiaman, D.
Submitted on February 3, 2008
Accepted on February 18, 2008

Endocannabinoid Involvement in Obesity and Hepatic Steatosis

George Kunos1* and Douglas Osei-Hyiaman1

1 NIAAA, NIH, Bethesda, Maryland, United States

* To whom correspondence should be addressed. E-mail: gkunos{at}mail.nih.gov.

Endocannabinoids are endogenous lipid mediators that interact with the same receptors as plant-derived cannabinoids to produce similar biological effects. The well known appetitive effect of smoking marijuana has prompted inquiries into the possible role of endocannabinoids in the control of food intake and body weight. This brief review surveys recent evidence that endocannabinoids and their receptors are involved at multiple levels in the control of energy homeostasis. Endocannabinoids are orexigenic mediators and are part of the leptin-regulated central neural circuitry that controls energy intake. In addition, they act at multiple peripheral sites, including adipose tissue, liver and skeletal muscle to promote lipogenesis and limit fat elimination. Their complex actions could be viewed as anabolic, increasing energy intake and storage and decreasing energy expenditure, as components of an evolutionarily conserved system that has insured survival under conditions of starvation. In the era of plentiful food and limited physical activity, pharmacological inhibition of endocannabinoid activity offers benefits in the treatment of obesity and its hormonal/metabolic consequences.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.